文献速递关节外科骨质疏松与代谢性骨病

关节内皮质类固醇注射增加膝关节置换风险

Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty.
PubMed 文献 · Bone Joint J · 2020-01-01

基于OAI多中心观察队列中3,822例有症状或风险膝骨关节炎患者,采用时间依赖倾向评分匹配和Cox回归分析,发现接受关节内皮质类固醇注射者后续膝关节置换风险显著升高(HR 1.57,95%CI 1.37–1.81,p<0.001),每接受一次注射九年绝对风险增加9.4%。

要点

  • 有症状或风险膝OA患者接受关节内皮质类固醇注射与膝关节置换风险升高相关。
  • 匹配队列中HR为1.57(95%CI 1.37–1.81,p<0.001)。
  • 每接受一次注射,九年随访时膝关节置换绝对风险增加9.4%。

核心结论

  • 关节内皮质类固醇注射似乎与有症状或风险膝骨关节炎患者膝关节置换风险增加相关。
  • 研究结果建议对此类患者采用保守的皮质类固醇注射治疗策略。

研究设计与样本

  • 使用Osteoarthritis Initiative(OAI)多中心观察队列数据,随访4,796例有症状或风险膝骨关节炎患者,最长九年。
  • 排除失访后3,822例进入分析,采用链式方程多重插补处理缺失数据。
  • 采用时间依赖倾向评分匹配,将首次注射时患者与对照匹配。
  • 使用Cox比例风险生存分析估计皮质类固醇注射对后续全膝和部分膝关节置换率的影响。

主要发现

  • 796例接受皮质类固醇注射的患者中249例(31.3%)发生膝关节置换,3,026例未注射者中152例(5.0%)发生膝关节置换。
  • 匹配队列中Cox回归风险比为1.57(95%CI 1.37–1.81;p<0.001)。
  • 每接受一次注射,九年随访时膝关节置换绝对风险较未注射者增加9.4%。

关键数值与推荐

  • 症状性OA风险增加定义为频繁膝症状(疼痛、酸痛或僵硬)但无OA放射学证据且具备两项及以上危险因素。
  • OA定义为存在股骨骨赘且单膝或双膝有频繁症状。

临床怎么用

  • 对有症状或风险膝骨关节炎患者,应谨慎使用关节内皮质类固醇注射,优先考虑保守治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Recent studies have suggested that corticosteroid injections into the knee may harm the joint resulting in cartilage loss and possibly accelerating the progression of osteoarthritis (OA). The aim of this study was to assess whether patients with, or at risk of developing, symptomatic osteoarthritis of the knee who receive intra-articular corticosteroid injections have an increased risk of requiring arthroplasty. METHODS: We used data from the Osteoarthritis Initiative (OAI), a multicentre observational cohort study that followed 4,796 patients with, or at risk of developing, osteoarthritis of the knee on an annual basis with follow-up available up to nine years. Increased risk for symptomatic OA was defined as frequent knee symptoms (pain, aching, or stiffness) without radiological evidence of OA and two or more risk factors, while OA was defined by the presence of both femoral osteophytes and frequent symptoms in one or both knees. Missing data were imputed with multiple imputations using chained equations. Time-dependent propensity score matching was performed to match patients at the time of receving their first injection with controls. The effect of corticosteroid injections on the rate of subsequent (total and partial) knee arthroplasty was estimated using Cox proportional-hazards survival analyses. RESULTS: After removing patients lost to follow-up, 3,822 patients remained in the study. A total of 249 (31.3%) of the 796 patients who received corticosteroid injections, and 152 (5.0%) of the 3,026 who did not, had knee arthroplasty. In the matched cohort, Cox proportional-hazards regression resulted in a hazard ratio of 1.57 (95% confidence interval (CI) 1.37 to 1.81; p < 0.001) and each injection increased the absolute risk of arthroplasty by 9.4% at nine years' follow-up compared with those who did not receive injections. CONCLUSION: Corticosteroid injections seem to be associated with an increased risk of knee arthroplasty in patients with, or at risk of developing, symptomatic OA of the knee. These findings suggest that a conservative approach regarding the treatment of these patients with corticosteroid injections should be recommended. Cite this article: Bone Joint J 2020;102-B(5):586-592.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Wijn SRW, Rovers MM, van Tienen TG, et al. Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty. Bone Joint J. 2020. PMID: 32349592. doi:10.1302/0301-620X.102B5.BJJ-2019-1376.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。